DOXERCALCIFEROL

SynDRA canonical compound SYN0023210 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · Rx/OTC
Primary target(s)	VDR
Mechanism of action	vitamin D receptor agonist
Indication	chronic kidney disease (CKD) \| hyperparathyroidism
Disease area	endocrinology \| nephrology

All known targets

hectorol
1-.alpha.-hydroxyergocalciferol
1-alpha-hydroxyergocalciferol
1-hydroxyergocalciferol
1.alpha.-hydroxyergocalciferol
1.alpha.-hydroxyvitamin d2
GZ427397
TSA-840
Hectorol
Doxcercalciferol
Doxercalciferol [INN]
TSA 840
BCI-101
Doxercalciferol (INN)
Hectorol (TN)
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(E,2R,5R)-5,6-dimethylhept-3-en-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol
(5Z,7E,22E)-9,10-Secoergosta-5,7,10(19),22-tetraene-1alpha,3beta-diol
1-Hydroxyergocalciferol
1-alpha-Hydroxyvitamin D2
1alpha-Hydroxyergocalciferol
1alpha-OH-D2
9,10-Secoergosta-5,7,10(19),22-tetraene-1,3-diol,(1-alpha,3-beta,5Z,7E,22E)
1alpha-hydroxyvitamin D2
1-Hydroxyvitamin D2
1.alpha.-Hydroxyvitamin D2
3DIZ9LF5Y9
(1S,3R,5Z,7E,22E)-9,10-Secoergosta-5,7,10,22-tetraene-1,3-diol
CHEBI:4712
1alpha-hydroxyvitamin D2 / 1alpha-hydroxyergocalciferol
(5Z,7E,22E)-(1S,3R)-9,10-seco-5,7,10(19),22-ergostatetraene-1,3-diol
(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-7a-methyl-1-[(E,1R,4R)-1,4,5-trimethylhex-2-enyl]-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylene-cyclohexane-1,3-diol
Vitamin D2, 1alpha-Hydroxy-
UNII-3DIZ9LF5Y9
BRN 4716774
Doxercalciferol [USAN:INN]
Doxercalciferolum
NCGC00182058-03
1alphaOHD2